ArticleMolecular oncology2015

Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.

Stian Knappskog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.